{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:50:53Z","timestamp":1790344253483,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105217","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:19:23Z","timestamp":1771226363000},"page":"105217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Microbiome-gut-liver axis in chronic inflammation and cancer immunotherapy: Multi-omics Insights and a translational roadmap toward personalized medicine"],"prefix":"10.1016","volume":"221","author":[{"given":"Shuwei","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105217_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.34172\/apb.2021.052","article-title":"Importance of nano medicine and new drug therapies for cancer","volume":"11","author":"Abdolmaleki","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.critrevonc.2026.105217_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10561-020-09844-1","article-title":"Protective effects of acetyl-l-carnitine against serum and glucose deprivation-induced apoptosis in rat adipose-derived mesenchymal stem cells","volume":"21","author":"Abdolmaleki","year":"2020","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.critrevonc.2026.105217_bib3","doi-asserted-by":"crossref","unstructured":"Abdolmaleki, A., Nahumi, A., Seddigh, H.B., Yazdannasab, N., Panahi, A., Ashique, S., Asadi, A., n.d. CRISPR System and its Applications in Medicine and Stem Cell Engineering. Gene Cell Tissue 11.","DOI":"10.5812\/gct-150914"},{"key":"10.1016\/j.critrevonc.2026.105217_bib4","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1021\/acsbiomaterials.4c01039","article-title":"Investigation of folate-functionalized magnetic-gold nanoparticles based targeted drug delivery for liver: in vitro, in vivo and docking studies","volume":"10","author":"Alnasraui","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.critrevonc.2026.105217_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2297860","article-title":"Multi-omic approaches for host-microbiome data integration","volume":"16","author":"Chetty","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.critrevonc.2026.105217_bib8","series-title":"Peoceeding of Approved: The Life Cycle of Drug Development","first-page":"549","article-title":"Regulatory Strategy","author":"Chirmule","year":"2025"},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib10","series-title":"Proceeding of Advances in Cancer Detection, Prediction, and Prognosis Using Artificial Intelligence and Machine Learning","first-page":"139","article-title":"Genomics and bioinformatics in the discovery and validation of diagnostic biomarkers","author":"Dubey","year":"2025"},{"key":"10.1016\/j.critrevonc.2026.105217_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: Relationships with disease and opportunities for therapy","volume":"216","author":"Durack","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105217_bib12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105217_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105217_bib14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/JHC.S322289","article-title":"Current Landscape and future directions of biomarkers for immunotherapy in hepatocellular carcinoma","author":"Gok Yavuz","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2026.105217_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105217_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib17","article-title":"Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing","volume":"3","author":"Group","year":"2024","journal-title":"Front. Micro."},{"key":"10.1016\/j.critrevonc.2026.105217_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12967-023-03938-6","article-title":"Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues","volume":"21","author":"He","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105217_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiz045","article-title":"Issues and current standards of controls in microbiome research","volume":"95","author":"Hornung","year":"2019","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib20","first-page":"413","article-title":"Immunomodulatory functions of mesenchymal stem cells in tissue engineering","volume":"80","author":"Hosseini","year":"2025","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.critrevonc.2026.105217_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-024-01285-9","article-title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events","volume":"16","author":"Hu","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.critrevonc.2026.105217_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2024.129446","article-title":"Investigation of dextran-coated magnetic nanoparticles encapsulated by medication and modified with folate for targeted drug delivery: invitro and docking studies","volume":"321","author":"Hussein F Alnasraui","year":"2024","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.critrevonc.2026.105217_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2021.151832","article-title":"Effect of astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines","volume":"124","author":"Karimian","year":"2022","journal-title":"Acta Histochem."},{"key":"10.1016\/j.critrevonc.2026.105217_bib25","article-title":"The impact of new coronavirus on cancer patients","author":"Karimian","year":"2021","journal-title":"J. Pharm. Care"},{"key":"10.1016\/j.critrevonc.2026.105217_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.58209\/ijbc.14.2.92","article-title":"Applications of nanofibers in the diagnosis and treatment of cancer","volume":"14","author":"Khoshnazar","year":"2022","journal-title":"Iran. J. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105217_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004779","article-title":"Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma","volume":"10","author":"Lee","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105217_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104163","article-title":"Gut microbiome in modulating immune checkpoint inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105217_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2560019","article-title":"Regulatory roles of intestinal CD4+ T cells in inflammation and their modulation by the intestinal microbiota","volume":"17","author":"Ma","year":"2025","journal-title":"Gut Microbes"},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib30","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10561-024-10130-7","article-title":"Biomechanical evaluation of a sheep tracheal scaffold","volume":"25","author":"Nahumi","year":"2024","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.critrevonc.2026.105217_bib33","first-page":"418","article-title":"Computational study on the binding of tracheal scaffold extracellular matrix fibronectin to the integrin of adipose tissue stem cells","volume":"23","author":"Nahumi","year":"2024","journal-title":"J. Ardabil Univ. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105217_bib34","first-page":"1","article-title":"Development and characterization of decellularized sheep ureter scaffolds for cell-based tissue engineering","author":"Nansa","year":"2025","journal-title":"Regen. Eng. Transl. Med."},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut\u2013liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2217\/fvl-2021-0160","article-title":"Can anti-parasitic drugs help control COVID-19?","volume":"17","author":"Panahi","year":"2022","journal-title":"Future Virol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib38","first-page":"1595","article-title":"Clinical evidence for microbiome-based strategies in cancer immunotherapy: a state-of-the-art review","volume":"61","author":"Petrelli","year":"2025","journal-title":"Med."},{"key":"10.1016\/j.critrevonc.2026.105217_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3747\/co.26.5177","article-title":"Impact of the gut microbiome on immune checkpoint inhibitor efficacy\u2014a systematic review","volume":"26","author":"Pierrard","year":"2019","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib40","article-title":"Integrated microbiome-metabolome profiling unveils a predictive signature for early recurrence in hepatocellular carcinoma","volume":"16","author":"Qu","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib41","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat. Commun."},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib42","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105217_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.premed.2025.100018","article-title":"Microbiome-guided precision medicine: mechanistic insights, multi-omics integration, and translational horizons","author":"Shahid","year":"2025","journal-title":"J. Precis. Med. Health Dis."},{"key":"10.1016\/j.critrevonc.2026.105217_bib44","first-page":"9","article-title":"The effect of Stem Cells in the Treatment of Leukemia","volume":"15","author":"Shekarian","year":"2023","journal-title":"Basic Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105217_bib45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/JHC.S315696","article-title":"An exploratory study for the association of gut microbiome with efficacy of immune checkpoint inhibitor in patients with hepatocellular carcinoma","volume":"8","author":"Shen","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2026.105217_bib46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41571-023-00803-9","article-title":"Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors","volume":"20","author":"Simpson","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib48","series-title":"International Conference on Prognostics and Health Management","first-page":"1","article-title":"Standardizing research methods for prognostics, in: 2008","author":"Uckun","year":"2008"},{"key":"10.1016\/j.critrevonc.2026.105217_bib49","series-title":"Proceeding of Human Microbiome: Techniques, Strategies, and Therapeutic Potential","first-page":"657","article-title":"Regulatory considerations for microbiome-based therapeutics","author":"Waheed","year":"2024"},{"key":"10.1016\/j.critrevonc.2026.105217_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","article-title":"Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer","volume":"32","author":"Wang","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.critrevonc.2026.105217_bib51","article-title":"Integrative multi-omics approaches to explore immune cell functions: challenges and opportunities","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2026.105217_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41420-025-02413-z","article-title":"Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.critrevonc.2026.105217_bib53","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/lifemeta\/loac034","article-title":"A multi-omic landscape of steatosis-to-NASH progression","volume":"1","author":"Xiang","year":"2022","journal-title":"Life Metab."},{"key":"10.1016\/j.critrevonc.2026.105217_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12967-024-05036-7","article-title":"The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma","volume":"22","author":"Xue","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105217_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/gastro\/goab046","article-title":"Microbiome therapeutics: exploring the present scenario and challenges","volume":"10","author":"Yadav","year":"2022","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105217_bib56","article-title":"Comprehensive analysis of microbiota signature across 32 cancer types","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105217_bib57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fmre.2024.11.001","article-title":"Engineered bacteria: Strategies and applications in cancer immunotherapy","volume":"5","author":"Zhang","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.critrevonc.2026.105217_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105217_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40364-024-00607-8","article-title":"Gut microbiota and metabolites signatures of clinical response in anti-PD-1\/PD-L1 based immunotherapy of biliary tract cancer","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark. Res."},{"issue":"1979","key":"10.1016\/j.critrevonc.2026.105217_bib60","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:49:43Z","timestamp":1775908183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"alternative-id":["S1040842826001046"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105217","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome-gut-liver axis in chronic inflammation and cancer immunotherapy: Multi-omics Insights and a translational roadmap toward personalized medicine","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105217"}}